Overall rank by patents
#24,337
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS).
The verdict
Fakespace holds 11 US patents across 4 technology areas, rank #24,337 of 50,000 tracked assignees.
Fakespace Labs, Inc. has been granted 11 US utility patents between 2015 and 2022, placing Fakespace Labs, Inc. at rank #24,337 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.7 claims per patent with primary concentration in G02B (OPTICAL ELEMENTS, SYSTEMS OR APPARATUS). As a US Corporation, Fakespace Labs, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Fakespace sits between Furyu Corporation (11 patents, rank #24,333) and Figure Eight Technologies, Inc. (11 patents, rank #24,341) - the closest US assignees by grant volume. The composite Innovation Score of 24.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 7 in the 2015–2019 window, a -43% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fakespace Labs, Inc.'s 7.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fakespace Labs, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FURYU CORPORATION
11 patents
FUTEK Advanced Sensor Technology
11 patents
Factom, Inc.
11 patents
Factorial Inc.
11 patents
Feiloli Electronic Co., Ltd.
11 patents
Fendi Adele S.r.l.
11 patents
Fibria Innovations Inc.
11 patents
Figure Eight Technologies, Inc.
11 patents
Fakespace Labs, Inc.
11 patents
What this shows Fakespace holds 11 patents at rank #24,337, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Fakespace's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 27.3% |
| 2017 | 2 | 18.2% |
| 2018 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2021 | 2 | 18.2% |
| 2022 | 2 | 18.2% |
Top 4 of 4 technology areas
Overall rank by patents
#24,337
Across all tracked assignees
24.7 out of 100
How to use this portfolio
Fakespace's 11 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.